First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Stock Price Down 0.5% – Should You Sell?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) shares fell 0.5% during mid-day trading on Friday . The stock traded as low as $166.08 and last traded at $167.18. 7,851 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 26,785 shares. The stock had previously closed at $167.98.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 0.5 %

The company has a market cap of $1.26 billion, a price-to-earnings ratio of 17.20 and a beta of 0.86. The stock’s 50-day simple moving average is $171.05 and its 200 day simple moving average is $166.59.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 17,093.0% during the third quarter. International Assets Investment Management LLC now owns 185,512 shares of the company’s stock worth $31,895,000 after purchasing an additional 184,433 shares during the period. Garden State Investment Advisory Services LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the third quarter valued at approximately $4,494,000. D.A. Davidson & CO. increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 60.9% during the 3rd quarter. D.A. Davidson & CO. now owns 60,339 shares of the company’s stock worth $10,374,000 after buying an additional 22,829 shares during the period. Benjamin Edwards Inc. lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 3,463.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 21,201 shares of the company’s stock worth $3,645,000 after buying an additional 20,606 shares in the last quarter. Finally, Assetmark Inc. boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 235.8% in the 3rd quarter. Assetmark Inc. now owns 28,452 shares of the company’s stock valued at $4,892,000 after buying an additional 19,978 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.